A. Harry and W. , Yeast-Like fungi of the Human intestinal tract. The journal of Infectious Diseases, oct, vol.341, issue.86, 1917.

J. Lodder, Torulopsis or Cryptococcus?, Mycopathologia, vol.1, issue.1, pp.62-69, 1938.
DOI : 10.1007/BF00440372

Y. David, M. Sally, A. , L. David, J. et al., Proposal for amendment of the diagnosis of the genus Candida Berkhout nom. cons Evolutionary Relationships among Pathogenic Candida Species and Relatives, Int J Syst Bacteriol. oct J Bacteriol. avr, vol.28173, issue.47, pp.2250-2255, 1978.

A. Bialková and J. Subík, Biology of the pathogenic yeastCandida glabrata, Folia Microbiologica, vol.142, issue.1, pp.3-20, 2006.
DOI : 10.1128/AAC.37.9.1847

R. Koszul, A. Malpertuy, L. Frangeul, C. Bouchier, P. Wincker et al., The complete mitochondrial genome sequence of the pathogenic yeast Candida (Torulopsis) glabrata Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata, FEBS Lett. 16 janv, vol.534, 2003.

W. Wright and R. Wenzel, Nosocomial Candida. Epidemiology, transmission, and prevention, 411? 25. 12. Odds FC, Jacobsen MD. Multilocus Sequence Typing of Pathogenic Candida Species. Eukaryot Cell. 1 juill, pp.1174-83, 1997.
DOI : 10.1016/s0891-5520(05)70363-9

C. Klaassen, isolates, Medical Mycology, vol.47, issue.s1, pp.27-33, 2009.
DOI : 10.1080/13693780802382244

URL : https://hal.archives-ouvertes.fr/hal-00670235

A. Dodgson, C. Pujol, D. Denning, D. Soll, and A. Fox, Multilocus Sequence Typing of Candida glabrata Reveals Geographically Enriched Clades, Journal of Clinical Microbiology, vol.41, issue.12, pp.5709-5726, 2003.
DOI : 10.1128/JCM.41.12.5709-5717.2003

URL : http://jcm.asm.org/content/41/12/5709.full.pdf

X. Zhao, ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p, Microbiology, vol.150, issue.7, pp.2415-2443, 2004.
DOI : 10.1099/mic.0.26943-0

URL : http://mic.microbiologyresearch.org/deliver/fulltext/micro/150/7/2415.pdf?itemId=/content/journal/micro/10.1099/mic.0.26943-0&mimeType=pdf&isFastTrackArticle=

A. De-las-peñas, S. Pan, I. Castaño, J. Alder, R. Cregg et al., Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing, Genes & Development, vol.17, issue.18
DOI : 10.1101/gad.1121003

C. Blankenship, J. Mitchell, and A. , How to build a biofilm: a fungal perspective, Current Opinion in Microbiology, vol.9, issue.6
DOI : 10.1016/j.mib.2006.10.003

S. Pan, M. Zupancic, C. Hennequin, B. Dujon, B. Cormack et al., Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata Candida glabrata Biofilms: How Far Have We Come? J Fungi. 1 mars 2017 Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem, Opin Microbiol. déc Mol Microbiol. févr Clin Microbiol Rev. 1 janv, vol.955320, issue.221, pp.1246-58, 2005.

E. Johnson, Rare and emerging Candida species, Current Fungal Infection Reports, vol.51, issue.3, pp.152-161, 2009.
DOI : 10.1093/clinids/18.1.77

P. Eggimann, J. Garbino, and D. Pittet, Epidemiology of Candida species infections in critically ill non-immunosuppressed patients, The Lancet Infectious Diseases, vol.3, issue.11, pp.685-702, 2003.
DOI : 10.1016/S1473-3099(03)00801-6

P. Eggimann and D. Pittet, Candid??mie et candidose g??n??ralis??e, EMC - Anesth??sie-R??animation, vol.7, issue.1
DOI : 10.1016/S0246-0289(10)50741-2

. Réanimation, M. Janv-pfaller, S. Messer, A. Houston, M. Rangel-frausto et al., National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species, Diagn Microbiol Infect Dis. mai Netea MG, vol.731, issue.11, pp.1-25, 1998.

M. Netea, G. Brown, B. Kullberg, and N. Gow, An integrated model of the recognition of Candida albicans by the innate immune system, Immune defence against Candida fungal infections, pp.630-672, 2008.
DOI : 10.4049/jimmunol.179.9.5999

O. Renaudat, C. Sitbon, K. Madec, Y. Denoeud-ndam, and L. , 1163? 9. 30. The French Mycosis Study Group Worrisome trends in incidence and mortality of candidemia in intensive care units Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program, Population-Based Analysis of Invasive Fungal Infections, pp.1519-1546, 2001.

M. Nucci, E. Anaissie, O. Leroy, J. Gangneux, P. Montravers et al., Revisiting the Source of Candidemia: Skin or Gut? Clin Infect Dis. 15 déc, pp.1959-67, 2001.

. Crit-care-med, A. Mai-holley, J. Dulhunty, S. Blot, . J. Lipman et al., Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units, Int J Antimicrob Agents. juin, vol.37337, issue.56, pp.1612-1620, 2009.

O. Épidémiologie-des-candidémies-de-la-france-lortholary, F. Dromer, B. Coignard, and C. D. , Mycoses invasives en France métropolitaine, PMSI 2001-2010 : incidence, létalité et tendances. bulletin épidémiologique hebdomadaire, Médecine Mal Infect. déc, vol.39, issue.12, 2009.

C. Cassagne, N. A. , L. Ollivier, C. Ranque, S. Piarroux et al., Performance of MALDI-TOF MS platforms for fungal identificationMALDI-TOF mass spectrometry to identify clinical bacterial isolates: evaluation in a teaching hospital in Lille], Mycoses. nov Pathol Biol, vol.59, issue.11, 2016.

J. Rex, Clinical and Laboratory Standards Institute, éditeurs. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard

P. Wayne, National Committee for Clinical Laboratory Standards, 2008.

S. Abbes, H. Trabelsi, I. Amouri, H. Sallemi, S. Nej et al., Methods for studying the in vitro susceptibility of Candida spp. to antifungals, Ann Biol Clin

D. Carolis, E. Vella, A. Florio, A. Posteraro, P. Perlin et al., Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species Finding the « missing 50% » of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care, Third European Conference on Infections in Leukemia Group. The use of mannan antigen and antimannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia, pp.2479-83, 2010.

T. Avni, L. Leibovici, and M. Paul, PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis, Journal of Clinical Microbiology, vol.49, issue.2, pp.665-70, 2011.
DOI : 10.1128/JCM.01602-10

H. Khodadadi, L. Karimi, N. Jalali-zand, H. Adin, and H. Mirhendi, Utilization of size polymorphism in ITS1 and ITS2 regions for identification of pathogenic yeast species, Journal of Medical Microbiology, vol.66, issue.2, 2017.
DOI : 10.1099/jmm.0.000426

C. León, S. Ruiz-santana, P. Saavedra, B. Galván, A. Blanco et al., Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Candida score " for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study: Crit Care Med, Clin Infect Dis. 15 juin, vol.4637, issue.125, pp.1813-1834, 2008.

M. Bassetti, M. Marchetti, A. Chakrabarti, S. Colizza, J. Garnacho-montero et al., A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts, Intensive Care Medicine, vol.46, issue.3, pp.2092-106, 2013.
DOI : 10.1128/JCM.02091-07

M. P. Nucci, B. Candidemia, A. Colombo, and T. Guimaraes, Causes and Investigations Evaluation of the clinical significance of persistent candidemia: results from a prospective study (abstract), Curr Fungal Infect Rep. mars, vol.5, issue.2007, 2011.

E. Velasco and R. Bigni, A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia, European Journal of Clinical Microbiology & Infectious Diseases, vol.22, issue.11, pp.1071-1079, 2008.
DOI : 10.1093/clinids/23.3.506

K. Apostolou and V. Pappas, Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies, 3300? 8. 58. Falagas ME, pp.419-444, 2006.

Y. Cohen, Facteurs pronostiques des infections à Candida: un enjeu pour améliorer la prise en charge et diminuer la mortalité des patients, Réanimation. oct, issue.4, pp.4-6, 2008.

E. Dannaoui, R. Duschinsky, E. Pleven, and C. Heidelberger, Principaux antifongiques systémiques Mécanismes d'action et de résistance, spectre, indications. DIU Stratégie thérapeutiques en Maladies infectieuses; mai The synthesis of 5-Fluoropyrimidines, J, vol.61, 2007.

. Fluorocytosine and M. Madoff, Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine. A new antifungal agent Flucytosine kinetics in subjects with normal and impaired renal function, Antimicrob Agents Chemother. mai JAMA. 21 oct Clin Pharmacol Ther. sept, vol.16120624, issue.43, pp.830-832, 1963.

A. Lemke, A. Kiderlen, O. Kayser, B. Amphotericin, K. Marx et al., Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent, Appl Microbiol Biotechnol. août Pharmacotherapy. nov, vol.6835, issue.211, pp.1037-51, 2005.

R. Fromtling, S. Normark, and J. Schönebeck, In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata):114? 21. 69. Polak A. 5-Fluorocytosine-current status with special references to mode of action and drug resistance Molecular mechanisms of primary resistance to flucytosine in Candida albicans, Clin Microbiol Rev. avr Antimicrob Agents Chemother. sept Contrib Microbiol Immunol. avr Antimicrob Agents Chemother. nov, vol.12448, issue.2311, pp.187-217, 1972.

P. Vandeputte, L. Pineau, G. Larcher, T. Noel, D. Brèthes et al., Molecular Mechanisms of Resistance to 5-Fluorocytosine in Laboratory Mutants of Candida glabrata, Mycopathologia, vol.49, issue.1
DOI : 10.1099/00221287-136-8-1475

URL : https://hal.archives-ouvertes.fr/hal-00520997

S. Farahyar, F. Zaini, P. Kordbacheh, S. Rezaie, M. Falahati et al., Cyp51p) to azole resistance in Candida albicans Pt 10):2701? 13. 75 Expression of Efflux Pumps and Fatty Acid Activator One Genes in Azole Resistant Candida Glabrata Isolated From Immunocompromised Patients Espinel-Ingroff A. Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi, Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, pp.458-64101, 1999.

B. Alexander, M. Johnson, C. Pfeiffer, C. Jiménez-ortigosa, J. Catania et al., Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations Clin Infect Dis Off Publ Infect Dis Soc Am, 84? 95. 79. Perlin DS. Echinocandin Resistance in Candida, pp.1724-1756, 2013.

. Multi-parametric, Quantification of the Cellular Interactions between Candida Yeasts and Phagocytes. Davis D, éditeur. PLoS ONE, p.32621, 2012.

M. Arendrup and M. Pfaller, the Danish Fungaemia Study Group. Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

. Acquisition-of-flucytosine, C. Azole, L. Castain, A. Pons, S. Jacob et al., Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant Recipient Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment, ):1360? 2. 84. Imbert S, 2010.

L. Walker, N. Gow, and C. Munro, Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin, Antimicrobial Agents and Chemotherapy, vol.57, issue.1, pp.146-54, 2008.
DOI : 10.1128/AAC.01486-12

D. Perlin, Mechanisms of echinocandin antifungal drug resistance, Annals of the New York Academy of Sciences, vol.333, issue.Suppl 7
DOI : 10.1126/science.1206412